Gisele Dion

Insider Reports History

Entity
Individual
Location
C/O Cytek Biosciences, Inc., 46107 Landing Parkway, Fremont, CA
Signature
/s/ Milton H. Werner, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gisele Dion:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cytek Biosciences, Inc. Director Stock Option (right to buy) 30.2K Jun 14, 2023 Direct
Inhibikase Therapeutics, Inc. Director Stock Option (right to buy) 30K Jul 16, 2024 Direct

Insider Reports Filed by Gisele Dion

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKT Inhibikase Therapeutics, Inc. Jul 16, 2024 1 $0 4 Jul 18, 2024 Director
IKT Inhibikase Therapeutics, Inc. Jun 30, 2023 1 $0 4 Jul 5, 2023 Director
CTKB Cytek Biosciences, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
IKT Inhibikase Therapeutics, Inc. Sep 1, 2022 1 $0 4 Sep 6, 2022 Director
IKT Inhibikase Therapeutics, Inc. Sep 1, 2022 0 $0 3 Sep 6, 2022 Director
CTKB Cytek Biosciences, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
CTKB Cytek Biosciences, Inc. Jul 22, 2021 1 $85K 4 Jul 27, 2021 Director
CTKB Cytek BioSciences, Inc. Jul 22, 2021 0 $0 3 Jul 22, 2021 Director